Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1408-1420
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1408
Table 5 Association of APOB -516C/T and LDLR A1413G polymorphism with lipid levels in normal weight Mestizos individuals
VariableAPOB -516 C/T genotypes
P valueLDLR A1413G genotypes
P value
CC (n = 85)
CT (n = 54)
TT (n = 15)
AA (n = 22)
AG (n = 65)
GG (n = 63)
TC (mg/dL)177.8 ± 31178.2 ± 37.4196.2 ± 27.60.033a177.2 ± 25.7175.4 ± 33.1182.9 ± 34.70.366
TG (mg/dL)110.4 ± 68119.9 ± 71.3108.7 ± 25.90.574106.9 ± 47.598.7 ± 44.6124.3 ± 79.80.094
LDL-c (mg/dL)106.3 ± 24107.3 ± 30.6129.5 ± 31.60.017a103.3 ± 23.9106.2 ± 26.8111.8 ± 29.50.042b
VLDL-c (mg/dL)22 ± 13.624.3 ± 14.321.8 ± 5.10.45121.3 ± 9.519.7 ± 9.025.1 ± 16.00.075
HDL-c (mg/dL)49.3 ± 13.948.5 ± 10.750.3 ± 16.90.90851.1 ± 15.351.6 ± 11.846.8 ± 13.30.143
Dyslipidemia, n (%)
HChol9 (11)8 (15)6 (40)0.012a1 (5)8 (12)14 (22)0.034b
HTG15 (18)14 (26)0 (0)0.0763 (14)7 (11)15 (24)0.315
High LDL-c13 (15)12 (22)7 (47)0.007a3 (14)10 (15)17 (27)0.046b
HALP19 (22)10 (18)3 (20)0.7603 (14)8 (12)18 (13)0.178